Anzeige
Mehr »
Login
Sonntag, 05.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
InnoCan Pharma: Multi-Milliarden-Wert in diesem Pennystock?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
55 Leser
Artikel bewerten:
(0)

Medical Education Program Trends that are Transforming the Medical Device and Pharmaceutical Marketplaces

CHAPEL HILL, N.C., April 5, 2013 /PRNewswire/ --The regulatory and financial environment has made it challenging for Medical Education groups to accomplish their principal goal of educating healthcare practitioners on the safe and effective use of new therapies. These dual challenges - one affecting program content and delivery and the other affecting resources - have made it even more vital for Medical Education groups to utilize high-impact presenters and venues and to efficiently use their resources.

Just as important is that Medical Education leaders create a way to demonstrate the value of education and training programs to corporate leadership.

To help inform Medical Education leaders on these critical challenges, research and consulting firm Best Practices, LLC conducted a new research study that pinpoints how organizations are developing and delivering education programs and which presenters and venues have the highest impact for physicians. In addition, the study reviews how organizations are allocating their education budgets and developing performance measures for their group's effectiveness.

The study, "Professional Medical Education Excellence: Benchmarking Critical Program Trends Transforming the Medical Device and Biopharmaceutical Marketplace," provides segments for both pharmaceutical and medical device companies.

Benchmarks and insights are presented on these topics:

  • Funding channels utilized by Medical Education groups
  • Effectiveness of different Medical Education program types and delivery channels
  • Use of multidisciplinary Medical Education programs
  • Trends in grants to professional societies/associations for accredited and non-accredited education programs
  • Rating of company professionals most valued by physicians for education
  • Future trends in Medical Education programs and technology

The study also informs education leaders on trends in the use of technology for education, and the presence of education in emerging markets.

The research project includes observations and insights from 32 leaders with 31 medical device and pharmaceutical companies. Participants included 14 medical education leaders from 14 medical device firms and 18 leaders from 17 biopharmaceutical companies.

To learn more about this report, download a complimentary report excerpt at http://www3.best-in-class.com/rr1211.htm. For related research, visit our Best Practices, LLC Web site at www.best-in-class.com/.

ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.

SOURCE Best Practices, LLC

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2013 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.